European Market Access.
Your Strategy. One Partner. All of Europe.
Euro Axxess Partners
Pan-European Market Access, Reimbursement & Pricing Consulting
Euro Axxess Partners helps international pharmaceutical companies design and execute robust European market access strategies that withstand national HTA decisions, pricing pressure and reimbursement uncertainty.
We combine:
-
Senior national market access experts in all key European markets
-
with a central European governance and strategy model
So you get one coherent European strategy – not many disconnected national opinions.
Copyright fotomek
The Challenges
European launch expectations may not be fully met in individual countries if national dynamics are not sufficiently anticipated or governed.
This can occur when:
-
National HTA requirements challenge assumptions underlying European pricing logic
-
Country-specific expectations differ from European benchmarks
-
Local optimisation unintentionally affects cross-country pricing or access dynamics
Our role is to anticipate these situations early and manage them within a structured European framework.
About us
Euro Axxess Partners is a pan-European market access consulting network combining senior national expertise with a clear European governance and strategy framework.
We help pharmaceutical companies translate European market access strategies into predictable national outcomes, while protecting pricing integrity and long-term European value.
Our Governance Model
European Market Access increasingly requires coordination combined with governance.
Euro Axxess Partners operates through a formal European governance model designed to ensure that:
-
National execution remains aligned with European strategy
-
Local adaptations are transparent and controlled
-
Pricing, reimbursement and launch decisions are assessed in an European context
Governance provides clarity, predictability and strategic confidence.
Our Services
Market Access Strategy
We develop European market access strategies that are robust, internally consistent and implementable at national level.
Our focus is not speed alone, but predictable, defensible and sustainable market access across Europe. We systematically analyse the key drivers and risks that influence reimbursement outcomes in each country and their interactions at European level.
Key strategic questions we address:
-
Which launch sequence minimises pricing and reimbursement risk across reference baskets?
-
Where do national payer requirements threaten European consistency?
-
Which countries require early mitigation strategies due to HTA or political uncertainty?
Our services include:
-
Clear European value positioning
-
Risk-adjusted launch sequencing across reference baskets
-
Early identification of HTA, pricing and political risks
Reimbursement & HTA
We support companies in preparing high-quality, regulatorily compliant and strategically aligned reimbursement dossiers.
Our approach ensures that national submissions:
-
fully comply with local requirements
-
are consistent with the European value story
-
do not create unintended pricing or reimbursement spill-over risks
In light of increasing European coordination through Joint Clinical Assessments (JCAs), we place particular emphasis on ensuring that European clinical narratives are translated into nationally defensible reimbursement arguments, without fragmenting the overall strategy.
Our services include:
-
High-quality, locally compliant submissions
-
Fully aligned with the European value story
-
Prepared for Joint Clinical Assessments (JCAs)
Pricing
Pricing decisions are among the most irreversible in market access. We therefore approach pricing with a risk-management mindset.
Our pricing experts analyse national and international reference pricing systems, most-favoured-nation rules and market dynamics to define pricing strategies that protect long-term European value, not just short-term access.
We support clients in defining:
-
European pricing corridors and red lines
-
country-specific pricing strategies within these boundaries
-
escalation scenarios when national price requests threaten European integrity
Our services include:
-
European pricing corridors and red lines
-
Country-specific strategies within a controlled framework
-
Protection of long-term European value
Negotiation Preparation
Successful negotiations depend on preparation, realism and strategic discipline.
We prepare national negotiation teams for high-stakes reimbursement and pricing negotiations by simulating payer interactions under realistic conditions.
Our simulations reflect:
-
actual national negotiation behaviour
-
political and budgetary constraints
-
typical payer counter-arguments
This enables teams to:
-
test negotiation strategies against European pricing limits
-
anticipate payer tactics
-
enter negotiations with clarity and confidence
